Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):400-2. doi: 10.1097/QAI.0b013e318263a111.

Abstract

A mild but significant association between a decrease in the total community viral load (CVL) and a decrease in the number of new HIV diagnoses was observed between 2005 and 2010 in the population of northern and eastern France. This result suggests that CVL could be used as robust marker of the efficacy of the "Treatment as Prevention" strategy, and it may even be stronger if a large number of undiagnosed patients and early HIV infection cases indicated by extend screening are included in the CVL measurement.

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Early Diagnosis
  • Female
  • France / epidemiology
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Poisson Distribution
  • Residence Characteristics / statistics & numerical data
  • Viral Load* / drug effects